RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Winder Laboratories, LLC 2024-06-19 Health serious FDA
Health · FDA · Recall #FDA-D-0545-2024

Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by:… Recall

Issued June 19, 2024 · Winder Laboratories, LLC

In June 2024, Winder Laboratories, LLC recalled the Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by:…, a serious health recall reported by the FDA.

Compiled by Maya Ellison, RecallCheckr

What this means for you

Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

What you should do

  1. 1 Stop using Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by:… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Winder Laboratories, LLC to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Winder Laboratories, LLC
Category
Health
Recall date
June 19, 2024
Units affected
Not reported
Sold at
Nationwide within the United States
Recall number
FDA-D-0545-2024
Made in
United States
Issuing agency
FDA

In context

  • Winder Laboratories, LLC has 3 recalls in our database.
  • We're tracking 3,576 Health recalls in our database.
  • This is the 737th Health recall we've logged in 2024.
Read the official FDA notice

Related recalls